About Index Trending news
Analyze
Top 50 Pricing
AVROBIO

AVROBIO

Work at AVROBIO? Add yourself to this profile

AVROBIO

Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$25,000,000
Employees

Unknown size

Locations
HQ
$25,000,000 Venture capital (Series A)
businesswire

AVROBIO, Inc. Announces $25 Million Series A Financing to Advance Novel, Clinical-Stage Gene Therapies for Rare Diseases and Cancer | Business Wire